Association between glycodelin and aryl hydrocarbon receptor in Iranian breast cancer patients: Impact of environmental endocrine disrupting chemicals

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2431-2435

  Bidgoli, Sepideh Arbabi ^a   Korani, Mitra ^a   Bozorgi, Niloofar ^a   Zavarhei, Mansour Djamali ^b   Ziarati, Parisa ^a   Akbarzadeh, Saeed ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AhR; Breast cancer; Endocrine disruption; Iran

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CARCINOGEN; ENDOCRINE DISRUPTOR; GLYCOPROTEIN; LIGAND; PAEP PROTEIN, HUMAN; PLACENTA PROTEIN;

ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; FIBROADENOMA; HUMAN; IRAN; METABOLISM; MIDDLE AGED; PATHOLOGY; POLLUTANT; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

BREAST NEOPLASMS; CARCINOGENS, ENVIRONMENTAL; ENDOCRINE DISRUPTORS; ENDOMETRIUM; ENVIRONMENTAL POLLUTANTS; EPITHELIAL CELLS; FEMALE; FIBROADENOMA; GLYCOPROTEINS; HUMANS; IRAN; LIGANDS; MIDDLE AGED; PREGNANCY PROTEINS; PROGNOSIS; RECEPTORS, ARYL HYDROCARBON; RETROSPECTIVE STUDIES; RISK FACTORS; TETRACHLORODIBENZODIOXIN;

EID: 84866290700     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Band PR, Le ND, Fang R et al. (2002). Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet, 360, 1044-9.
2. Bidgoli SA, Ahmadi R, Zavarhei MD (2010). Role of hormonal and environmental factors on early incidence of breast cancer in Iran. Sci Total Environ, 408, 4056-61.
3. Bofinger DP, Feng L, Chi LH, et al. (2001). Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium. Toxicol Sci, 62, 299-314.
4. Chlebowski RT (2000). Reducing the risk of breast cancer. N Engl J Med, 343, 191-8.
5. Hajian-Tilaki KO, Gholizadehpasha AR, Bozorgzadeh S, et al. (2011). Body mass index and waist circumference are predictor biomarkers of breast cancer risk in Iranian women. Med Oncol, 28, 1296-301.
6. Hautala LC, Greco D, Koistinen R, et al. (2011). Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients. Breast Cancer Res Treat, 128, 85-95.
7. Hurst CH, Abbott BD, Devito MJ, et al. (1998). 2,3,7,8-Tetrachlorodibenzo-p-dioxin in pregnant Long Evans rats: disposition to maternal and embryo/fetal tissues. Toxicol Sci, 45, 129-36.
8. Jeschke U, Mylonas I, Kunert-Keil C, et al. (2005). Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Oncol Rep, 13, 413-9.
9. Koistinen H, Hautala LC, Seppala M, et al. (2009). The role of glycodelin in cell differentiation and tumor growth. Scand J Clin Lab Invest, 69, 452-9.
10. Lux MP, Ackermann S, Nestle-Kramling C, et al. (2005). Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer. Eur J Cancer Prev, 14, 399-411.
11. Mueller MD, Vigne JL, Streich M, et al. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases glycodelin gene and protein expression in human endometrium. J Clin Endocrinol Metab, 90, 4809-15.
12. Onland-Moret NC, Kaaks R, van Noord PA, et al. (2003). Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer. Br J Cancer, 88, 1394-9.
13. Pliskova M, Vondracek J, Vojtesek B, et al. (2005). Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events. Toxicol Sci, 83, 246-56.
14. Scholz C, Toth B, Barthell E, et al. (2009). Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity. Histol Histopathol, 24, 467-71.
15. Seppala M, Koistinen H, Koistinen R, et al. (2009). Glycodelin in reproductive endocrinology and hormone-related cancer. Eur J Endocrinol, 160, 121-33.
16. Van der HE, Bechoux N, Muller M, et al. (2009). Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays. Anal Chim Acta, 637, 337-45.
17. Wong PS, Li W, Vogel CF, et al. (2009). Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR). BMC Cancer, 9, 234.
18. Yavari P, Mosavizadeh M, Sadrol-Hefazi B, et al. (2005). Reproductive characteristics and the risk of breast cancer-a case-control study in Iran. Asian Pac J Cancer Prev, 6, 370-5.
19. Zhang S, Lei P, Liu X, et al. (2009). The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy. Endocr Relat Cancer, 16, 835-44.
20. Zlobec I, Steele R, Michel RP, et al. (2006). Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer. Mod Pathol, 19, 1236-42.